Compound Detail
CHEMBL3683695
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COC1CCN(CCN2CCC[C@H](n3nc(C(=O)N4CCOCC4)c4c3-c3ccc(F)cc3S(=O)(=O)C4)C2)CC1
Basic Information
| ChEMBL ID | CHEMBL3683695 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FGJSGEOFFFKFLV-NRFANRHFSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
575.7
MW (Da)
2.20
ALogP
9
HBA
0
HBD
97.2
PSA (Ų)
0.52
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.89
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| PI3-kinase class I CHEMBL3559703 | IC50 | 7.89 | 7.89 | 13.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| PI3-kinase class I | IC50 | = | 13.0 | nM | 7.89 | Binding Assay: The efficacy of compounds of the invention in inhibiting the PI3K... | - |
Data from ChEMBL 36 via Core Engine